 David Allen
Concepts (455)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myostatin | 9 | 2011 | 26 | 2.330 |
Why?
| | Muscle, Skeletal | 34 | 2015 | 1472 | 2.220 |
Why?
| | Muscle Fibers, Skeletal | 16 | 2011 | 185 | 1.990 |
Why?
| | Myosin Heavy Chains | 18 | 2011 | 177 | 1.830 |
Why?
| | Antigens, Human Platelet | 7 | 2013 | 9 | 1.460 |
Why?
| | Isoantibodies | 6 | 2013 | 57 | 1.190 |
Why?
| | Food Deprivation | 4 | 2010 | 24 | 1.160 |
Why?
| | Gene Expression Regulation | 11 | 2010 | 2319 | 1.070 |
Why?
| | Muscular Atrophy | 4 | 2010 | 78 | 1.020 |
Why?
| | Physical Conditioning, Animal | 7 | 2020 | 194 | 0.970 |
Why?
| | Muscle Fibers, Fast-Twitch | 7 | 2010 | 15 | 0.950 |
Why?
| | Promoter Regions, Genetic | 12 | 2010 | 1131 | 0.950 |
Why?
| | Adaptation, Physiological | 9 | 2011 | 483 | 0.930 |
Why?
| | Matrix Metalloproteinase 9 | 4 | 2013 | 119 | 0.870 |
Why?
| | Hindlimb | 6 | 2011 | 130 | 0.720 |
Why?
| | Calcineurin | 5 | 2010 | 89 | 0.680 |
Why?
| | Integrin beta3 | 4 | 2013 | 9 | 0.610 |
Why?
| | Transcription, Genetic | 8 | 2020 | 1313 | 0.600 |
Why?
| | Blood Platelets | 3 | 2011 | 351 | 0.600 |
Why?
| | Exercise | 4 | 2015 | 1644 | 0.560 |
Why?
| | Edetic Acid | 3 | 2013 | 47 | 0.550 |
Why?
| | Mice | 35 | 2011 | 14859 | 0.540 |
Why?
| | Thrombocytopenia, Neonatal Alloimmune | 2 | 2013 | 2 | 0.540 |
Why?
| | Myoblasts | 3 | 2008 | 76 | 0.530 |
Why?
| | Hindlimb Suspension | 4 | 2010 | 24 | 0.520 |
Why?
| | RNA, Messenger | 14 | 2010 | 2552 | 0.500 |
Why?
| | Animals | 54 | 2020 | 31692 | 0.490 |
Why?
| | Transforming Growth Factor beta | 3 | 2008 | 448 | 0.480 |
Why?
| | Elbow Joint | 2 | 2015 | 59 | 0.480 |
Why?
| | Space Flight | 4 | 2008 | 127 | 0.460 |
Why?
| | Muscle Development | 5 | 2010 | 98 | 0.450 |
Why?
| | Integrin alpha2 | 1 | 2013 | 3 | 0.440 |
Why?
| | Chelating Agents | 1 | 2013 | 65 | 0.430 |
Why?
| | Weightlessness | 4 | 2008 | 79 | 0.420 |
Why?
| | Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2011 | 22 | 0.400 |
Why?
| | Iron Chelating Agents | 1 | 2011 | 16 | 0.390 |
Why?
| | Dexamethasone | 2 | 2010 | 317 | 0.390 |
Why?
| | Organ Size | 12 | 2010 | 434 | 0.380 |
Why?
| | Transcription Factors | 6 | 2020 | 1527 | 0.370 |
Why?
| | Mice, Inbred C57BL | 12 | 2011 | 4689 | 0.370 |
Why?
| | CCAAT-Enhancer-Binding Protein-delta | 1 | 2010 | 4 | 0.360 |
Why?
| | Molecular Sequence Data | 10 | 2010 | 2785 | 0.360 |
Why?
| | Tolloid-Like Metalloproteinases | 1 | 2010 | 1 | 0.360 |
Why?
| | Bone Morphogenetic Protein 1 | 1 | 2010 | 1 | 0.360 |
Why?
| | Smad Proteins | 2 | 2010 | 39 | 0.360 |
Why?
| | Elbow | 1 | 2011 | 52 | 0.360 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2010 | 82 | 0.340 |
Why?
| | Epitopes | 2 | 2011 | 435 | 0.340 |
Why?
| | Physical Exertion | 5 | 2015 | 209 | 0.320 |
Why?
| | Adipose Tissue | 3 | 2011 | 539 | 0.310 |
Why?
| | Regulatory Sequences, Nucleic Acid | 2 | 2008 | 81 | 0.310 |
Why?
| | Protein Isoforms | 7 | 2008 | 338 | 0.310 |
Why?
| | DNA, Intergenic | 1 | 2008 | 24 | 0.300 |
Why?
| | Motor Activity | 7 | 2005 | 640 | 0.300 |
Why?
| | Activin Receptors, Type II | 1 | 2008 | 9 | 0.300 |
Why?
| | Genes, MHC Class II | 1 | 2008 | 69 | 0.300 |
Why?
| | CLOCK Proteins | 2 | 2020 | 8 | 0.300 |
Why?
| | Base Sequence | 7 | 2010 | 2114 | 0.300 |
Why?
| | Obesity | 2 | 2011 | 2507 | 0.290 |
Why?
| | Antibodies, Monoclonal | 4 | 2011 | 1262 | 0.290 |
Why?
| | MicroRNAs | 2 | 2010 | 600 | 0.290 |
Why?
| | Genotype | 4 | 2011 | 1760 | 0.280 |
Why?
| | Muscle Fibers, Slow-Twitch | 5 | 2010 | 13 | 0.280 |
Why?
| | Drosophila Proteins | 3 | 2020 | 164 | 0.270 |
Why?
| | Cell Nucleus | 7 | 2001 | 554 | 0.270 |
Why?
| | Circadian Rhythm | 3 | 2020 | 354 | 0.270 |
Why?
| | Transfection | 7 | 2008 | 866 | 0.270 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2007 | 106 | 0.260 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 797 | 0.260 |
Why?
| | Interleukin-6 | 1 | 2009 | 676 | 0.260 |
Why?
| | Calcium Signaling | 2 | 2009 | 213 | 0.250 |
Why?
| | Forkhead Transcription Factors | 1 | 2006 | 170 | 0.250 |
Why?
| | Muscular Diseases | 2 | 2011 | 104 | 0.250 |
Why?
| | DNA-Binding Proteins | 4 | 2009 | 1313 | 0.240 |
Why?
| | Purpura, Thrombocytopenic | 1 | 2004 | 5 | 0.240 |
Why?
| | Serum Response Factor | 1 | 2005 | 29 | 0.240 |
Why?
| | Platelet Transfusion | 2 | 2004 | 64 | 0.240 |
Why?
| | Insulin-Like Growth Factor I | 5 | 2003 | 286 | 0.240 |
Why?
| | Growth Hormone | 4 | 1998 | 103 | 0.230 |
Why?
| | Physical Endurance | 2 | 2002 | 232 | 0.230 |
Why?
| | Cells, Cultured | 8 | 2010 | 3881 | 0.230 |
Why?
| | Cell Differentiation | 3 | 2010 | 1699 | 0.220 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2011 | 1879 | 0.220 |
Why?
| | Infant, Newborn, Diseases | 1 | 2004 | 104 | 0.210 |
Why?
| | Male | 26 | 2022 | 55549 | 0.210 |
Why?
| | Growth Substances | 1 | 2002 | 138 | 0.210 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 923 | 0.210 |
Why?
| | Stress, Psychological | 1 | 2010 | 944 | 0.210 |
Why?
| | Rats | 12 | 2011 | 4958 | 0.200 |
Why?
| | Proteins | 1 | 2008 | 908 | 0.200 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2002 | 172 | 0.200 |
Why?
| | Matrix Metalloproteinases | 1 | 2002 | 89 | 0.200 |
Why?
| | Nuclear Proteins | 3 | 2006 | 591 | 0.190 |
Why?
| | Cell Line | 5 | 2010 | 2635 | 0.180 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2006 | 800 | 0.180 |
Why?
| | Mice, Transgenic | 5 | 2011 | 1947 | 0.180 |
Why?
| | Proteomics | 3 | 2020 | 835 | 0.180 |
Why?
| | Circadian Clocks | 1 | 2020 | 42 | 0.180 |
Why?
| | Heart | 4 | 2005 | 612 | 0.170 |
Why?
| | Histone Acetyltransferases | 1 | 2020 | 51 | 0.170 |
Why?
| | Bariatric Surgery | 1 | 2022 | 161 | 0.170 |
Why?
| | Cardiovascular Physiological Phenomena | 1 | 2020 | 40 | 0.170 |
Why?
| | Acclimatization | 1 | 2001 | 149 | 0.170 |
Why?
| | Binding Sites | 5 | 2007 | 1168 | 0.170 |
Why?
| | Drosophila | 1 | 2020 | 133 | 0.170 |
Why?
| | Corticosterone | 2 | 2010 | 211 | 0.160 |
Why?
| | Mutation | 4 | 2011 | 3344 | 0.160 |
Why?
| | Fibronectins | 4 | 2002 | 108 | 0.160 |
Why?
| | Weight-Bearing | 3 | 2001 | 165 | 0.160 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 7 | 2009 | 318 | 0.150 |
Why?
| | Muscle Proteins | 2 | 2010 | 210 | 0.150 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2011 | 2094 | 0.150 |
Why?
| | Thrombocytopenia | 3 | 2004 | 177 | 0.140 |
Why?
| | Protein Binding | 3 | 2020 | 1888 | 0.140 |
Why?
| | Calcium | 1 | 2002 | 1104 | 0.140 |
Why?
| | Mice, Knockout | 5 | 2010 | 2565 | 0.140 |
Why?
| | Female | 22 | 2022 | 59461 | 0.140 |
Why?
| | Staphylococcus aureus | 2 | 2011 | 385 | 0.140 |
Why?
| | Humans | 32 | 2022 | 114616 | 0.130 |
Why?
| | Luciferases | 2 | 2008 | 142 | 0.130 |
Why?
| | Glucocorticoids | 2 | 2010 | 532 | 0.130 |
Why?
| | NFATC Transcription Factors | 2 | 2009 | 78 | 0.130 |
Why?
| | Fluorescent Antibody Technique | 2 | 2009 | 397 | 0.130 |
Why?
| | Body Weight | 6 | 2003 | 868 | 0.120 |
Why?
| | Microscopy, Confocal | 6 | 2001 | 304 | 0.120 |
Why?
| | Genetic Variation | 4 | 2007 | 870 | 0.120 |
Why?
| | Signal Transduction | 5 | 2009 | 4509 | 0.120 |
Why?
| | Hypertrophy | 3 | 2001 | 109 | 0.120 |
Why?
| | Infant, Newborn | 5 | 2013 | 5040 | 0.120 |
Why?
| | Bacterial Proteins | 2 | 2011 | 736 | 0.110 |
Why?
| | Aging | 2 | 2001 | 1618 | 0.110 |
Why?
| | Immunoassay | 1 | 1994 | 95 | 0.110 |
Why?
| | Isometric Contraction | 2 | 2015 | 155 | 0.110 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2013 | 24 | 0.110 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2006 | 345 | 0.110 |
Why?
| | Amino Acid Sequence | 5 | 2009 | 1982 | 0.110 |
Why?
| | Species Specificity | 2 | 2020 | 542 | 0.110 |
Why?
| | Immunity, Maternally-Acquired | 1 | 1992 | 18 | 0.110 |
Why?
| | Range of Motion, Articular | 2 | 2015 | 350 | 0.110 |
Why?
| | Education | 1 | 2013 | 95 | 0.100 |
Why?
| | Vancomycin Resistance | 2 | 2011 | 15 | 0.100 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1394 | 0.100 |
Why?
| | Weight Loss | 2 | 2022 | 641 | 0.100 |
Why?
| | Blotting, Western | 3 | 2010 | 1147 | 0.100 |
Why?
| | Sensitivity and Specificity | 2 | 2013 | 1691 | 0.100 |
Why?
| | Apoptosis | 2 | 1999 | 2362 | 0.100 |
Why?
| | Time Factors | 3 | 2010 | 6112 | 0.100 |
Why?
| | Rats, Sprague-Dawley | 6 | 2003 | 2218 | 0.100 |
Why?
| | Quality of Life | 1 | 2022 | 2353 | 0.100 |
Why?
| | Gluconeogenesis | 2 | 2010 | 62 | 0.100 |
Why?
| | Antigen-Antibody Complex | 1 | 2011 | 84 | 0.100 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2011 | 63 | 0.100 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2008 | 152 | 0.100 |
Why?
| | Running | 1 | 2013 | 207 | 0.090 |
Why?
| | Proteome | 2 | 2007 | 338 | 0.090 |
Why?
| | Genes, Bacterial | 2 | 2008 | 157 | 0.090 |
Why?
| | Muscle Fatigue | 2 | 2011 | 94 | 0.090 |
Why?
| | Torque | 1 | 2011 | 66 | 0.090 |
Why?
| | Protein Kinase C | 2 | 2002 | 273 | 0.090 |
Why?
| | SKP Cullin F-Box Protein Ligases | 1 | 2010 | 9 | 0.090 |
Why?
| | Glucokinase | 1 | 2010 | 13 | 0.090 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 32 | 0.090 |
Why?
| | Tripartite Motif Proteins | 1 | 2010 | 30 | 0.090 |
Why?
| | DNA | 4 | 2008 | 1351 | 0.090 |
Why?
| | 3T3 Cells | 3 | 2008 | 140 | 0.090 |
Why?
| | Mice, Obese | 2 | 2008 | 53 | 0.090 |
Why?
| | Phosphatidylethanolamine Binding Protein | 1 | 2009 | 1 | 0.090 |
Why?
| | Oxazolidinones | 1 | 2009 | 14 | 0.080 |
Why?
| | Immunohistochemistry | 5 | 2003 | 1629 | 0.080 |
Why?
| | Adult | 8 | 2022 | 30528 | 0.080 |
Why?
| | Thymus Gland | 1 | 2010 | 296 | 0.080 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2010 | 139 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2008 | 398 | 0.080 |
Why?
| | Body Temperature Regulation | 2 | 2007 | 72 | 0.080 |
Why?
| | Skeletal Muscle Myosins | 1 | 2008 | 2 | 0.080 |
Why?
| | RNA, Antisense | 1 | 2008 | 17 | 0.080 |
Why?
| | Spleen | 1 | 2010 | 487 | 0.080 |
Why?
| | Follistatin-Related Proteins | 1 | 2008 | 1 | 0.080 |
Why?
| | Myogenic Regulatory Factors | 2 | 2005 | 49 | 0.080 |
Why?
| | Calcium-Binding Proteins | 1 | 2009 | 206 | 0.080 |
Why?
| | MEF2 Transcription Factors | 2 | 2005 | 55 | 0.080 |
Why?
| | Adolescent | 5 | 2022 | 17830 | 0.070 |
Why?
| | Muscle Contraction | 1 | 2011 | 389 | 0.070 |
Why?
| | Models, Animal | 1 | 2009 | 344 | 0.070 |
Why?
| | ADP Ribose Transferases | 1 | 2007 | 9 | 0.070 |
Why?
| | Eating | 1 | 2010 | 344 | 0.070 |
Why?
| | Creatine Kinase | 3 | 2015 | 75 | 0.070 |
Why?
| | Analysis of Variance | 1 | 2010 | 1226 | 0.070 |
Why?
| | Point Mutation | 1 | 2008 | 216 | 0.070 |
Why?
| | Multigene Family | 1 | 2008 | 190 | 0.070 |
Why?
| | Cluster Analysis | 1 | 2008 | 455 | 0.070 |
Why?
| | Up-Regulation | 1 | 2010 | 807 | 0.070 |
Why?
| | Young Adult | 4 | 2022 | 10455 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2009 | 386 | 0.070 |
Why?
| | Cloning, Molecular | 1 | 2008 | 522 | 0.070 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2008 | 329 | 0.070 |
Why?
| | Leptin | 1 | 2008 | 210 | 0.070 |
Why?
| | Protein Kinases | 1 | 2008 | 307 | 0.070 |
Why?
| | Forkhead Box Protein O1 | 1 | 2006 | 15 | 0.070 |
Why?
| | NF-kappa B | 1 | 2010 | 638 | 0.070 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2008 | 740 | 0.070 |
Why?
| | Animals, Newborn | 4 | 2001 | 778 | 0.070 |
Why?
| | Cerebrospinal Fluid | 1 | 2007 | 90 | 0.070 |
Why?
| | Myogenic Regulatory Factor 5 | 1 | 2006 | 4 | 0.070 |
Why?
| | Biomarkers | 3 | 2013 | 3405 | 0.070 |
Why?
| | Feeding Behavior | 2 | 2022 | 574 | 0.070 |
Why?
| | MyoD Protein | 1 | 2006 | 27 | 0.070 |
Why?
| | Anti-Inflammatory Agents | 1 | 2009 | 447 | 0.070 |
Why?
| | Dietary Fats | 1 | 2008 | 287 | 0.070 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2008 | 358 | 0.070 |
Why?
| | Reproducibility of Results | 2 | 2008 | 2762 | 0.060 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 993 | 0.060 |
Why?
| | Genes, Reporter | 2 | 2006 | 257 | 0.060 |
Why?
| | Statistics as Topic | 1 | 2007 | 292 | 0.060 |
Why?
| | Cattle | 1 | 2008 | 920 | 0.060 |
Why?
| | Octamer Transcription Factor-1 | 1 | 2005 | 4 | 0.060 |
Why?
| | Myocardium | 3 | 2005 | 913 | 0.060 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2007 | 285 | 0.060 |
Why?
| | Receptors, Nicotinic | 1 | 2007 | 274 | 0.060 |
Why?
| | Microspheres | 1 | 2005 | 123 | 0.060 |
Why?
| | Mice, Inbred Strains | 2 | 2002 | 396 | 0.060 |
Why?
| | Tobacco Use Disorder | 1 | 2007 | 234 | 0.060 |
Why?
| | Immunoglobulins | 1 | 2005 | 142 | 0.060 |
Why?
| | Affect | 1 | 2007 | 246 | 0.060 |
Why?
| | Life Style | 1 | 2007 | 430 | 0.060 |
Why?
| | Tissue Distribution | 1 | 2005 | 286 | 0.060 |
Why?
| | Phenotype | 5 | 2007 | 2796 | 0.060 |
Why?
| | Drosophila melanogaster | 2 | 2014 | 191 | 0.060 |
Why?
| | Oligonucleotides | 1 | 2005 | 137 | 0.060 |
Why?
| | Plasmids | 1 | 2005 | 343 | 0.060 |
Why?
| | Liver | 1 | 2011 | 1633 | 0.060 |
Why?
| | Cell Count | 3 | 2002 | 303 | 0.060 |
Why?
| | Desmin | 1 | 2003 | 31 | 0.050 |
Why?
| | Blood Proteins | 1 | 2005 | 231 | 0.050 |
Why?
| | Gene Deletion | 1 | 2005 | 356 | 0.050 |
Why?
| | Green Fluorescent Proteins | 1 | 2005 | 371 | 0.050 |
Why?
| | Peptide Fragments | 2 | 2000 | 665 | 0.050 |
Why?
| | Heart Rate | 1 | 2007 | 709 | 0.050 |
Why?
| | Transcriptional Activation | 1 | 2005 | 337 | 0.050 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2002 | 20 | 0.050 |
Why?
| | Gene Transfer Techniques | 2 | 2003 | 147 | 0.050 |
Why?
| | Enhancer Elements, Genetic | 2 | 2001 | 151 | 0.050 |
Why?
| | Calcimycin | 1 | 2002 | 47 | 0.050 |
Why?
| | Ionophores | 1 | 2002 | 22 | 0.050 |
Why?
| | Gene Expression | 4 | 2020 | 1421 | 0.050 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2002 | 57 | 0.050 |
Why?
| | Motivation | 1 | 2007 | 494 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2009 | 1139 | 0.050 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2002 | 83 | 0.050 |
Why?
| | Protein Structure, Tertiary | 1 | 2005 | 796 | 0.050 |
Why?
| | Anti-Bacterial Agents | 1 | 2011 | 1477 | 0.050 |
Why?
| | Calcineurin Inhibitors | 1 | 2002 | 58 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2008 | 1518 | 0.050 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2009 | 134 | 0.050 |
Why?
| | Selection, Genetic | 1 | 1984 | 242 | 0.050 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2002 | 39 | 0.050 |
Why?
| | Molecular Biology | 1 | 2002 | 56 | 0.050 |
Why?
| | T-Lymphocytes | 1 | 2009 | 1736 | 0.050 |
Why?
| | Cytokines | 1 | 2009 | 1840 | 0.050 |
Why?
| | Mice, SCID | 1 | 2002 | 314 | 0.050 |
Why?
| | Cost-Benefit Analysis | 1 | 2004 | 544 | 0.050 |
Why?
| | Brain Injuries | 1 | 2007 | 461 | 0.050 |
Why?
| | Child Abuse | 1 | 2007 | 456 | 0.050 |
Why?
| | Antibodies | 1 | 2004 | 371 | 0.050 |
Why?
| | Phosphorylation | 3 | 2014 | 1569 | 0.050 |
Why?
| | NADH Tetrazolium Reductase | 1 | 2001 | 2 | 0.050 |
Why?
| | Isoenzymes | 1 | 2002 | 283 | 0.050 |
Why?
| | Blood Glucose | 1 | 2010 | 1819 | 0.050 |
Why?
| | Cell Movement | 2 | 2002 | 868 | 0.050 |
Why?
| | Gravitation | 1 | 2001 | 20 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2002 | 278 | 0.050 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 3 | 2007 | 100 | 0.050 |
Why?
| | Diet | 1 | 2008 | 1080 | 0.050 |
Why?
| | MAP Kinase Signaling System | 1 | 2002 | 276 | 0.050 |
Why?
| | Sarcomeres | 1 | 2001 | 90 | 0.040 |
Why?
| | Homozygote | 1 | 2001 | 187 | 0.040 |
Why?
| | Chemotactic Factors | 1 | 2000 | 50 | 0.040 |
Why?
| | Animal Care Committees | 1 | 2020 | 6 | 0.040 |
Why?
| | Factor IX | 1 | 2000 | 34 | 0.040 |
Why?
| | Heterozygote | 1 | 2001 | 251 | 0.040 |
Why?
| | Dependovirus | 1 | 2000 | 52 | 0.040 |
Why?
| | Antigen-Antibody Reactions | 2 | 2002 | 50 | 0.040 |
Why?
| | Antigens, CD | 1 | 2002 | 442 | 0.040 |
Why?
| | Reference Values | 1 | 2001 | 742 | 0.040 |
Why?
| | Transgenes | 1 | 2000 | 170 | 0.040 |
Why?
| | Propionates | 1 | 1999 | 34 | 0.040 |
Why?
| | Myosins | 2 | 2000 | 126 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2002 | 750 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2000 | 289 | 0.040 |
Why?
| | RNA Interference | 1 | 2020 | 433 | 0.040 |
Why?
| | Flow Cytometry | 2 | 2009 | 1083 | 0.040 |
Why?
| | Period Circadian Proteins | 2 | 2014 | 12 | 0.040 |
Why?
| | Oligopeptides | 1 | 2000 | 236 | 0.040 |
Why?
| | Wound Healing | 1 | 2000 | 258 | 0.040 |
Why?
| | Cats | 2 | 1995 | 193 | 0.040 |
Why?
| | Genes, Insect | 1 | 1997 | 20 | 0.040 |
Why?
| | Alcoholism | 1 | 1984 | 713 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2008 | 353 | 0.040 |
Why?
| | Cytoplasm | 1 | 1997 | 255 | 0.030 |
Why?
| | Recombinant Proteins | 2 | 1997 | 1230 | 0.030 |
Why?
| | Cell Wall | 2 | 2011 | 52 | 0.030 |
Why?
| | Extracellular Matrix | 1 | 2000 | 435 | 0.030 |
Why?
| | DNA, Bacterial | 2 | 2008 | 311 | 0.030 |
Why?
| | Staphylococcal Infections | 2 | 2011 | 336 | 0.030 |
Why?
| | Chromatography, Liquid | 2 | 2009 | 347 | 0.030 |
Why?
| | Myalgia | 1 | 2015 | 15 | 0.030 |
Why?
| | Visual Analog Scale | 1 | 2015 | 31 | 0.030 |
Why?
| | Escherichia coli | 1 | 1999 | 720 | 0.030 |
Why?
| | Decerebrate State | 1 | 1995 | 4 | 0.030 |
Why?
| | Myosin Subfragments | 1 | 1995 | 22 | 0.030 |
Why?
| | Atrophy | 1 | 1995 | 152 | 0.030 |
Why?
| | Isoantigens | 1 | 1994 | 17 | 0.030 |
Why?
| | ARNTL Transcription Factors | 1 | 2014 | 13 | 0.030 |
Why?
| | Antibody Specificity | 1 | 1994 | 176 | 0.030 |
Why?
| | Receptors, Somatotropin | 1 | 1993 | 9 | 0.030 |
Why?
| | Pregnancy | 3 | 1992 | 5517 | 0.030 |
Why?
| | United Kingdom | 1 | 1994 | 226 | 0.030 |
Why?
| | Immunosorbent Techniques | 1 | 1992 | 17 | 0.030 |
Why?
| | Coombs Test | 1 | 1992 | 5 | 0.030 |
Why?
| | Volition | 2 | 2003 | 31 | 0.030 |
Why?
| | Mass Spectrometry | 2 | 2007 | 633 | 0.030 |
Why?
| | Prostatic Neoplasms | 1 | 2000 | 921 | 0.030 |
Why?
| | Citrate (si)-Synthase | 2 | 2003 | 46 | 0.030 |
Why?
| | Histocompatibility Testing | 1 | 1992 | 116 | 0.030 |
Why?
| | Diabetes Mellitus | 1 | 2000 | 900 | 0.030 |
Why?
| | Sequence Analysis, DNA | 2 | 2007 | 723 | 0.020 |
Why?
| | Molecular Typing | 1 | 2011 | 18 | 0.020 |
Why?
| | Daptomycin | 1 | 2011 | 18 | 0.020 |
Why?
| | Leg | 1 | 2013 | 225 | 0.020 |
Why?
| | HLA Antigens | 1 | 1992 | 224 | 0.020 |
Why?
| | Rh Isoimmunization | 1 | 1991 | 3 | 0.020 |
Why?
| | Abnormalities, Multiple | 1 | 1992 | 178 | 0.020 |
Why?
| | Rh-Hr Blood-Group System | 1 | 1991 | 11 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 4620 | 0.020 |
Why?
| | Muscle Strength | 1 | 2013 | 270 | 0.020 |
Why?
| | Cell Cycle | 1 | 1993 | 542 | 0.020 |
Why?
| | Vancomycin | 1 | 2011 | 75 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2020 | 3531 | 0.020 |
Why?
| | Microbial Sensitivity Tests | 1 | 2011 | 300 | 0.020 |
Why?
| | Receptors, Fibronectin | 2 | 2000 | 6 | 0.020 |
Why?
| | Virulence Factors | 1 | 2011 | 139 | 0.020 |
Why?
| | Rats, Wistar | 2 | 2001 | 368 | 0.020 |
Why?
| | Clonal Anergy | 1 | 2009 | 53 | 0.020 |
Why?
| | Biofilms | 1 | 2011 | 223 | 0.020 |
Why?
| | Oxidation-Reduction | 2 | 2003 | 923 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 1994 | 1796 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2000 | 1879 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 157 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2011 | 439 | 0.020 |
Why?
| | Kinetics | 3 | 2000 | 1551 | 0.020 |
Why?
| | Genetic Complementation Test | 1 | 2007 | 62 | 0.020 |
Why?
| | Genes, Regulator | 1 | 2007 | 34 | 0.020 |
Why?
| | Administration, Cutaneous | 1 | 2007 | 117 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2009 | 411 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2000 | 2177 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 510 | 0.020 |
Why?
| | Fibroblasts | 2 | 2003 | 837 | 0.020 |
Why?
| | Cystatins | 1 | 2007 | 7 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2007 | 167 | 0.020 |
Why?
| | Lipocalins | 1 | 2007 | 34 | 0.020 |
Why?
| | Cystatin C | 1 | 2007 | 62 | 0.020 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2007 | 57 | 0.020 |
Why?
| | Haptoglobins | 1 | 2007 | 47 | 0.020 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2007 | 124 | 0.020 |
Why?
| | Smoking Prevention | 1 | 2007 | 157 | 0.020 |
Why?
| | Immunoblotting | 1 | 2007 | 283 | 0.020 |
Why?
| | Nucleus Accumbens | 1 | 2007 | 124 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2009 | 1037 | 0.020 |
Why?
| | Cell Division | 2 | 2000 | 758 | 0.020 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2005 | 36 | 0.020 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2005 | 60 | 0.020 |
Why?
| | Albumins | 1 | 2005 | 89 | 0.020 |
Why?
| | Nicotine | 1 | 2007 | 265 | 0.020 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2005 | 77 | 0.010 |
Why?
| | Alcohol Withdrawal Delirium | 1 | 1984 | 8 | 0.010 |
Why?
| | Genes, Dominant | 1 | 1984 | 94 | 0.010 |
Why?
| | Purpura | 1 | 2004 | 13 | 0.010 |
Why?
| | Genomics | 1 | 2008 | 635 | 0.010 |
Why?
| | Exploratory Behavior | 1 | 1984 | 82 | 0.010 |
Why?
| | Isomerism | 1 | 2003 | 43 | 0.010 |
Why?
| | Smoking Cessation | 1 | 2007 | 374 | 0.010 |
Why?
| | Motor Skills | 1 | 1984 | 82 | 0.010 |
Why?
| | Muscle Cells | 1 | 2003 | 42 | 0.010 |
Why?
| | Protein Kinase C-epsilon | 1 | 2002 | 27 | 0.010 |
Why?
| | Peptide Mapping | 1 | 2002 | 60 | 0.010 |
Why?
| | Epitopes, B-Lymphocyte | 1 | 2002 | 16 | 0.010 |
Why?
| | RNA Precursors | 1 | 2003 | 136 | 0.010 |
Why?
| | CHO Cells | 1 | 2002 | 138 | 0.010 |
Why?
| | Coloring Agents | 1 | 2002 | 72 | 0.010 |
Why?
| | Cricetinae | 1 | 2002 | 253 | 0.010 |
Why?
| | Proto-Oncogene Proteins | 1 | 2005 | 608 | 0.010 |
Why?
| | Electrophoresis | 1 | 2001 | 26 | 0.010 |
Why?
| | Amino Acid Substitution | 1 | 2002 | 262 | 0.010 |
Why?
| | Seizures | 1 | 1984 | 340 | 0.010 |
Why?
| | Animals, Suckling | 1 | 2000 | 10 | 0.010 |
Why?
| | Autoimmune Diseases | 1 | 2004 | 382 | 0.010 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2002 | 470 | 0.010 |
Why?
| | Smoking | 1 | 2007 | 1380 | 0.010 |
Why?
| | Blotting, Southern | 1 | 2000 | 68 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2002 | 1016 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 2002 | 385 | 0.010 |
Why?
| | Basement Membrane | 1 | 2000 | 30 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 1999 | 94 | 0.010 |
Why?
| | Virion | 1 | 2000 | 73 | 0.010 |
Why?
| | Putrescine | 1 | 1999 | 2 | 0.010 |
Why?
| | Oxaloacetic Acid | 1 | 1999 | 3 | 0.010 |
Why?
| | Echocardiography | 1 | 2002 | 553 | 0.010 |
Why?
| | Acyl Coenzyme A | 1 | 1999 | 30 | 0.010 |
Why?
| | Formates | 1 | 1999 | 13 | 0.010 |
Why?
| | Citrates | 1 | 1999 | 43 | 0.010 |
Why?
| | Citric Acid Cycle | 1 | 1999 | 43 | 0.010 |
Why?
| | Methylmalonic Acid | 1 | 1999 | 59 | 0.010 |
Why?
| | Trehalose | 1 | 1999 | 30 | 0.010 |
Why?
| | Citric Acid | 1 | 1999 | 30 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 1999 | 292 | 0.010 |
Why?
| | Chemotaxis | 1 | 2000 | 130 | 0.010 |
Why?
| | Pyruvic Acid | 1 | 1999 | 42 | 0.010 |
Why?
| | Succinic Acid | 1 | 1999 | 44 | 0.010 |
Why?
| | Alanine | 1 | 1999 | 104 | 0.010 |
Why?
| | DNA, Single-Stranded | 1 | 2000 | 111 | 0.010 |
Why?
| | Protons | 1 | 1999 | 73 | 0.010 |
Why?
| | Carbon Isotopes | 1 | 1999 | 111 | 0.010 |
Why?
| | Keratinocytes | 1 | 2000 | 216 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2000 | 501 | 0.010 |
Why?
| | Sex Factors | 1 | 1984 | 1715 | 0.010 |
Why?
| | Glycine | 1 | 1999 | 152 | 0.010 |
Why?
| | Neoplasm Invasiveness | 1 | 2000 | 442 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2000 | 849 | 0.010 |
Why?
| | DNA, Viral | 1 | 2000 | 350 | 0.010 |
Why?
| | Neoplasm Metastasis | 1 | 2000 | 522 | 0.010 |
Why?
| | Glutamic Acid | 1 | 1999 | 211 | 0.010 |
Why?
| | Hemodynamics | 1 | 2002 | 1012 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1999 | 473 | 0.010 |
Why?
| | Feedback | 1 | 1997 | 144 | 0.010 |
Why?
| | Exercise Test | 1 | 1999 | 544 | 0.010 |
Why?
| | Cell Survival | 1 | 2000 | 1020 | 0.010 |
Why?
| | Brain | 1 | 2007 | 2371 | 0.010 |
Why?
| | Mass Screening | 1 | 2002 | 1004 | 0.010 |
Why?
| | Succinate Dehydrogenase | 1 | 1995 | 42 | 0.010 |
Why?
| | Age Factors | 1 | 2001 | 2894 | 0.010 |
Why?
| | Infant | 1 | 2007 | 7954 | 0.010 |
Why?
| | Thymidine | 1 | 1993 | 58 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2007 | 9084 | 0.010 |
Why?
| | Insulin | 2 | 1993 | 2076 | 0.010 |
Why?
| | Child, Preschool | 1 | 2007 | 9106 | 0.010 |
Why?
| | Glycerolphosphate Dehydrogenase | 1 | 1992 | 4 | 0.010 |
Why?
| | Adipocytes | 1 | 1993 | 188 | 0.010 |
Why?
| | Biomechanical Phenomena | 1 | 1995 | 668 | 0.010 |
Why?
| | England | 1 | 1991 | 65 | 0.010 |
Why?
| | Collagen | 1 | 1992 | 415 | 0.010 |
Why?
| | Fetal Blood | 1 | 1991 | 270 | 0.010 |
Why?
| | Pregnancy Outcome | 1 | 1991 | 337 | 0.000 |
Why?
| | Middle Aged | 1 | 2007 | 26719 | 0.000 |
Why?
| | Incidence | 1 | 1991 | 2311 | 0.000 |
Why?
| | Retrospective Studies | 1 | 1991 | 12542 | 0.000 |
Why?
|
|
Allen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|